PureTech Health PLC | Mutual Funds
Mutual Funds that own PureTech Health PLC
Invesco Perpetual UK Invt. Ser. - High Income
50,905,826
18.02%
12,824,262
0.84%
03/29/2018
Invesco Perpetual UK 2 Invt. Series - Income Fund
25,096,376
8.89%
6,343,828
0.86%
03/29/2018
Jupiter UK Growth Fund
11,916,813
4.22%
150,997
1.57%
02/28/2018
CF Ruffer Investment Funds - European Fund
7,335,000
2.6%
3,835,000
5.08%
04/30/2018
Invesco Perpetual UK 2 Invt. Series - UK Strategic Income Fund
6,168,702
2.18%
-5,700,000
2.08%
03/29/2018
Perpetual Income & Growth Investment Trust Plc
5,500,000
1.95%
500,000
0.78%
03/31/2018
Baillie Gifford Overseas Growth Fund - Global Discovery Fund
4,317,174
1.53%
0
1.33%
04/30/2018
Edinburgh Worldwide Investment Trust Plc
3,296,732
1.17%
0
1.09%
10/31/2017
Baillie Gifford UK & Balanced Fund - UK Equity Alpha Fund
3,290,308
1.17%
0
1.34%
04/30/2018
Majedie Asset Mgmt. Invt. Fd. - UK Focus Fund
3,281,782
1.15%
-331,304
0.53%
07/31/2018
| Address |
6 Tide Street
Boston Massachusetts 02210
United States
|
|
Employees
|
- |
| Website |
http://puretechhealth.com/ |
| Updated |
07/08/2019 |
| PureTech Health Plc is a cross-disciplinary biopharmacy company, which engages in the development of treatment programs for obesity, cognitive disorders, baldness, depression, allergy, and autoimmune. It operates through the following segments: Growth Stage Affiliates, Project Phase Programmes, Independent Affiliate Programmes, and Parent Company and Other. The Growth Stage Affiliates segment focuses on the development on products to solve major healthcare problems in varied markets. |
